These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11443877)

  • 21. Comprehensive analyses of a unique HIV-1-infected nonprogressor reveal a complex association of immunobiological mechanisms in the context of replication-incompetent infection.
    Wang B; Dyer WB; Zaunders JJ; Mikhail M; Sullivan JS; Williams L; Haddad DN; Harris G; Holt JA; Cooper DA; Miranda-Saksena M; Boadle R; Kelleher AD; Saksena NK
    Virology; 2002 Dec; 304(2):246-64. PubMed ID: 12504566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.
    Shiver JW; Fu TM; Chen L; Casimiro DR; Davies ME; Evans RK; Zhang ZQ; Simon AJ; Trigona WL; Dubey SA; Huang L; Harris VA; Long RS; Liang X; Handt L; Schleif WA; Zhu L; Freed DC; Persaud NV; Guan L; Punt KS; Tang A; Chen M; Wilson KA; Collins KB; Heidecker GJ; Fernandez VR; Perry HC; Joyce JG; Grimm KM; Cook JC; Keller PM; Kresock DS; Mach H; Troutman RD; Isopi LA; Williams DM; Xu Z; Bohannon KE; Volkin DB; Montefiori DC; Miura A; Krivulka GR; Lifton MA; Kuroda MJ; Schmitz JE; Letvin NL; Caulfield MJ; Bett AJ; Youil R; Kaslow DC; Emini EA
    Nature; 2002 Jan; 415(6869):331-5. PubMed ID: 11797011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 CCR5 gene therapy will fail unless it is combined with a suicide gene.
    Pandit A; de Boer RJ
    Sci Rep; 2015 Dec; 5():18088. PubMed ID: 26674113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD4+ CCR5+ T-cell dynamics during simian immunodeficiency virus infection of Chinese rhesus macaques.
    Monceaux V; Viollet L; Petit F; Cumont MC; Kaufmann GR; Aubertin AM; Hurtrel B; Silvestri G; Estaquier J
    J Virol; 2007 Dec; 81(24):13865-75. PubMed ID: 17898067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Viral evolution in macaques coinfected with CCR5- and CXCR4-tropic SHIVs in the presence or absence of vaccine-elicited anti-CCR5 SHIV neutralizing antibodies.
    Burke B; Derby NR; Kraft Z; Saunders CJ; Dai C; Llewellyn N; Zharkikh I; Vojtech L; Zhu T; Srivastava IK; Barnett SW; Stamatatos L
    Virology; 2006 Nov; 355(2):138-51. PubMed ID: 16920175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitat gene therapy: a candidate for late-stage AIDS patients.
    Lisziewicz J; Sun D; Lisziewicz A; Gallo RC
    Gene Ther; 1995 May; 2(3):218-22. PubMed ID: 7614253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV Persistence in Adipose Tissue Reservoirs.
    Couturier J; Lewis DE
    Curr HIV/AIDS Rep; 2018 Feb; 15(1):60-71. PubMed ID: 29423731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Establishment of mouse leukemia cell lines expressing human CD4/CCR5 using lentiviral vectors.
    Li YJ; ZhuGe FY; Zeng CC; He JY; Tan N; Liang J
    Virus Genes; 2017 Apr; 53(2):197-204. PubMed ID: 28028680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on HIV transmission and pathogenesis.
    Gozlan M
    Lancet; 1995 Nov; 346(8985):1290. PubMed ID: 7475727
    [No Abstract]   [Full Text] [Related]  

  • 30. CXCR6-Mediated Simian Immunodeficiency Virus SIVagmSab Entry into Sabaeus African Green Monkey Lymphocytes Implicates Widespread Use of Non-CCR5 Pathways in Natural Host Infections.
    Wetzel KS; Yi Y; Elliott STC; Romero D; Jacquelin B; Hahn BH; Muller-Trutwin M; Apetrei C; Pandrea I; Collman RG
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27903799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can gene delivery close the door to HIV-1 entry after escape?
    Swan CH; Torbett BE
    J Med Primatol; 2006 Aug; 35(4-5):236-47. PubMed ID: 16872287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques.
    Ho SH; Shek L; Gettie A; Blanchard J; Cheng-Mayer C
    J Virol; 2005 Oct; 79(19):12296-303. PubMed ID: 16160156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the pathogenic KU-SHIV model of acquired immunodeficiency syndrome in macaques.
    Joag SV; Li Z; Foresman L; Pinson DM; Raghavan R; Zhuge W; Adany I; Wang C; Jia F; Sheffer D; Ranchalis J; Watson A; Narayan O
    AIDS Res Hum Retroviruses; 1997 May; 13(8):635-45. PubMed ID: 9168232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of human immunodeficiency virus type 1 replication in primary macrophages by using Tat- or CCR5-specific small interfering RNAs expressed from a lentivirus vector.
    Lee MT; Coburn GA; McClure MO; Cullen BR
    J Virol; 2003 Nov; 77(22):11964-72. PubMed ID: 14581533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of a protective gene-prolongs survival of T cells in human immunodeficiency virus-infected patients.
    Woffendin C; Ranga U; Yang Z; Xu L; Nabel GJ
    Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2889-94. PubMed ID: 8610137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human immunodeficiency virus type I as a target for gene therapy.
    Gottfredsson M; Bohjanen PR
    Front Biosci; 1997 Dec; 2():d619-34. PubMed ID: 9388165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus.
    Kumar A; Mukherjee S; Shen J; Buch S; Li Z; Adany I; Liu Z; Zhuge W; Piatak M; Lifson J; McClure H; Narayan O
    Virology; 2002 Sep; 301(2):189-205. PubMed ID: 12359422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engineering HIV-Resistant, Anti-HIV Chimeric Antigen Receptor T Cells.
    Hale M; Mesojednik T; Romano Ibarra GS; Sahni J; Bernard A; Sommer K; Scharenberg AM; Rawlings DJ; Wagner TA
    Mol Ther; 2017 Mar; 25(3):570-579. PubMed ID: 28143740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of human immunodeficiency virus type 1 replication in vitro in acutely and persistently infected human CD4+ mononuclear cells expressing murine and humanized anti-human immunodeficiency virus type 1 Tat single-chain variable fragment intrabodies.
    Mhashilkar AM; LaVecchio J; Eberhardt B; Porter-Brooks J; Boisot S; Dove JH; Pumphrey C; Li X; Weissmahr RN; Ring DB; Ramstedt U; Marasco WA
    Hum Gene Ther; 1999 Jun; 10(9):1453-67. PubMed ID: 10395371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope.
    Emini EA; Koff WC
    Science; 2004 Jun; 304(5679):1913-4. PubMed ID: 15218131
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.